Literature DB >> 25816049

Increased Hair Cortisol Concentrations and BMI in Patients With Pituitary-Adrenal Disease on Hydrocortisone Replacement.

Sabine M Staufenbiel1, Cornelie D Andela1, Laura Manenschijn1, Alberto M Pereira1, Elisabeth F C van Rossum1, Nienke R Biermasz1.   

Abstract

CONTEXT: Intrinsic imperfections and lack of reliable biomarkers preclude optimal individual dosing of hydrocortisone replacement in adrenal insufficiency (AI). However, the clinical relevance of optimal dosing is exemplified by frequently occurring side effects of overreplacement and the dangers of underreplacement. Cortisol in scalp hair has been identified as a retrospective biomarker for long-term cortisol exposure. We compared hair cortisol concentrations (CORT(hair)) of patients with primary or secondary AI on replacement therapy with those of patient controls with a pituitary disease without AI (PCs) and of healthy controls (HCs).
METHODS: In this cross-sectional study, hair samples and anthropometric data were collected in 132 AI patients (52 males), 42 PCs (11 males), and 195 HCs (90 males). The proximal 3 cm of hair were used. CORT(hair) were measured using an ELISA.
RESULTS: CORT(hair) were higher in AI patients than in HCs and PCs (P < .001), and hydrocortisone dose correlated with CORT(hair) (P = .04). Male AI patients demonstrated higher CORT(hair) than female patients (P < .001). AI patients had higher body mass index (BMI) than HCs (P < .001), and BMI correlated with CORT(hair) in the whole sample (P < .001).
CONCLUSION: Physiological hydrocortisone replacement is associated with increased CORT(hair). The association between CORT(hair) and BMI could suggest a mild overtreatment that may lead to adverse anthropomorphic side effects, especially in males. CORT(hair) measurements may be a promising additional tool to monitor cumulative hydrocortisone replacement in AI.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25816049     DOI: 10.1210/jc.2014-4328

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Hair cortisol in the evaluation of Cushing syndrome.

Authors:  Aaron Hodes; Maya B Lodish; Amit Tirosh; Jerrold Meyer; Elena Belyavskaya; Charalampos Lyssikatos; Kendra Rosenberg; Andrew Demidowich; Jeremy Swan; Nichole Jonas; Constantine A Stratakis; Mihail Zilbermint
Journal:  Endocrine       Date:  2017-02-13       Impact factor: 3.633

2.  Subjective and physiological stress measurement in a multiple sclerosis sample and the relation with executive functions performance.

Authors:  Morgana Scheffer; Jefferson Becker; Lucas Araújo de Azeredo; Rodrigo Grassi-Oliveira; Rosa Maria Martins de Almeida
Journal:  J Neural Transm (Vienna)       Date:  2019-02-06       Impact factor: 3.575

3.  Genetic influences on hormonal markers of chronic hypothalamic-pituitary-adrenal function in human hair.

Authors:  E M Tucker-Drob; A D Grotzinger; D A Briley; L E Engelhardt; F D Mann; M Patterson; C Kirschbaum; E K Adam; J A Church; J L Tackett; K P Harden
Journal:  Psychol Med       Date:  2017-01-19       Impact factor: 7.723

4.  High prevalence of overweight/obesity and dyslipidemia in patients with intracranial germ cell tumors.

Authors:  Shirui Wang; Yuelun Zhang; Xiang Zhou; Kun Zhang; Yi Zhang; Yong Yao; Shi Chen; Hui Pan; Huijuan Zhu
Journal:  Pituitary       Date:  2022-09-10       Impact factor: 3.599

5.  The Association between Hair Cortisol and Self-Reported Symptoms of Depression in Pregnant Women.

Authors:  Ellen Wikenius; Vibeke Moe; Marian Kjellevold; Lars Smith; Robert Lyle; Rune Waagbø; Christian Magnus Page; Anne Margrethe Myhre
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

Review 6.  How non-functioning pituitary adenomas can affect health-related quality of life: a conceptual model and literature review.

Authors:  Cornelie D Andela; Daniel J Lobatto; Alberto M Pereira; Wouter R van Furth; Nienke R Biermasz
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

7.  Potential Transcriptional Biomarkers to Guide Glucocorticoid Replacement in Autoimmune Addison's Disease.

Authors:  Åse Bjorvatn Sævik; Anette B Wolff; Sigridur Björnsdottir; Katerina Simunkova; Martha Schei Hynne; David William Peter Dolan; Eirik Bratland; Per M Knappskog; Paal Methlie; Siri Carlsen; Magnus Isaksson; Sophie Bensing; Olle Kämpe; Eystein S Husebye; Kristian Løvås; Marianne Øksnes
Journal:  J Endocr Soc       Date:  2021-01-04

8.  Non-invasive assessment of tissue sodium content in patients with primary adrenal insufficiency.

Authors:  Irina Chifu; Andreas Max Weng; Stephanie Burger-Stritt; Thorsten Alexander Bley; Martin Christa; Herbert Köstler; Stefanie Hahner
Journal:  Eur J Endocrinol       Date:  2022-07-21       Impact factor: 6.558

Review 9.  Clinical Unmet Needs in the Treatment of Adrenal Crisis: Importance of the Patient's Perspective.

Authors:  Kim M J A Claessen; Cornelie D Andela; Nienke R Biermasz; Alberto M Pereira
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-20       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.